Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients

deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber...